Viewing nowAtor Tablet 10 mg (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

MFDS item code 200709790 · Notified 2007.08.24 · Insurance code 652900780
Improvement of hyperlipidemia and prevention of cardiovascular diseases (myocardial infarction, stroke, etc.)
This medicine is effective in reducing the risk of cardiovascular diseases. It particularly lowers the risk of myocardial infarction and stroke in elderly individuals and adults with various risk factors such as smoking or hypertension, as well as patients with type 2 diabetes. It also reduces the recurrence risk for patients who have undergone vascular interventions or suffer from angina and congestive heart failure. This drug helps improve cholesterol and triglyceride levels in patients with hyperlipidemia and is also effective in patients with familial hypercholesterolemia that is difficult to control by diet. It is used in pediatric patients with significant hypercholesterolemia to reduce the risk of cardiovascular disease. Overall, this drug is widely used for the prevention and management of cardiovascular diseases.
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medication may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended starting dose is 10 mg of atorvastatin once daily. However, patients who require a greater reduction in LDL cholesterol may start at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or greater is required). This medication is administered once daily at doses ranging from 10 ~ 80 mg. The initial and maintenance doses of this medication should be individualized according to the patient's characteristics, taking treatment goals and response into consideration. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Since the goal of treatment is to lower LDL cholesterol, LDL cholesterol is recommended for use at the start of treatment and when evaluating the treatment response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia This medication is administered at a dose of 10 ~ 80 mg once daily, in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are not available. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Older adults: The efficacy and safety in patients aged 70 years or older are similar to those in the general adult patient population.
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended starting dose is 10 mg of this medication once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses of this medication greater than 20 mg in pediatric patients). The dose should be adjusted as appropriate according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer.
This drug may cause muscle-related symptoms; if severe muscle pain or weakness occurs, or if creatine kinase levels become significantly elevated, discontinue use immediately. This drug can affect liver function, and should not be used in cases of liver disease or elevated liver enzyme levels. It is contraindicated in individuals with muscle disorders, pregnant or breastfeeding women, and children under 10 years of age. Caution should be exercised in alcoholics or patients with a history of liver disease, as the risk of myopathy is higher in the elderly. Regular monitoring of liver function tests and muscle status is important during treatment. Especially if symptoms such as muscle pain, weakness, or fever occur, contact a physician immediately. This drug may interact with other medications, so inform your doctor or pharmacist if you are taking any other medications. Women who may become pregnant should use appropriate contraception during treatment, and discontinue immediately if pregnancy is confirmed. Nursing mothers should not take this medication, and extra caution is required for children and the elderly. There is no specific antidote for overdose, thus symptomatic treatment should be implemented, monitoring liver function and muscle enzyme levels. This drug should be kept out of reach of children and stored in its original container to prevent quality degradation.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is advisable to maintain the storage temperature between 1°C and 30°C. This will help preserve the drug's effectiveness.
White round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.